Celadon Pharmaceuticals Company Description

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.

The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders.

Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Celadon Pharmaceuticals Plc

Country	United Kingdom
Founded	2018
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	27
CEO	James Short

Contact Details

Address: 32-33 Cowcross Street London, EC1M 6DF United Kingdom
Phone	44 20 3150 0252
Website	celadonpharma.com

Stock Details

Ticker Symbol	CEL
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BDQYGP38
SIC Code	6799

Key Executives

Name	Position
James Short	Chief Executive Officer
Jonathan Turner	Chief Financial Officer